RW treatment persistence and associated costs with biologic therapy in patients with Inflammatory Bowel Disease: Results of a retrospective cohort analysis from Germany

The poster “Real-world treatment persistence and associated costs with biologic therapy in patients with Inflammatory Bowel Disease (IBD): Results of a retrospective cohort analysis of 1,149 patients treated in Germany” will be presented at the 13th Congress of ECCO – Inflammatory Bowel Diseases 2018 (February 14-17, 2018 in Vienna, Austria). It summarizes the first results

Lees meer